HSTO stock forecast
Our latest prediction for Histogen Inc's stock price was made on the March 30, 2021 when the stock price was at 1.13$.
In the short term (2weeks), HSTO's stock price should outperform the market by 3.21%. During that period the price should oscillate between -11.21% and +18.37%.
In the medium term (3months), HSTO's stock price should outperform the market by 22.19%. During that period the price should oscillate between -47.04% and +64.96%.
Get email alertsCreate a solid portfolio with HSTO
About Histogen Inc
a regenerative medicine company based on naturally-produced products from newborn fibroblasts grown in a proprietary bioreactor. two product families - a proprietary liquid complex of embryonic-like proteins and growth factors, and a human extracellular matrix (ecm) material, exceltrix.
At the moment the company generates 2M USD in revenues.
On its last earning announcement, the company reported a loss of -2.08$ per share.
The book value per share is 0.22$
Three months stock forecastMarch 30, 2021
Financials
Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2M | 53.00% | -12M | -568.90% | -19M | -2.08 | - | - | 9M | 0.22 | -12M | - | -12M |